Stimwave Technologies Announces Partnership with Epimed International

Stimwave Technologies Announces Partnership with Epimed International

Stimwave Technologies Announces Partnership with Epimed International

MIAMI–(BUSINESS WIRE)–Stimwave Technologies Incorporated has announced a milestone partnership with Epimed International, a leading company in the development, design, manufacturing, and distribution of specialty devices focusing on pain management. The partnership, in addition to co-product development, will support distribution of Stimwave’s revolutionary Wireless Pain Relief™ technology, expanding the Stimwave USA network to more than 100 highly-trained sales representatives speaking directly to doctors, medical centers and hospitals across the country. Stimwave’s wireless neuromodulation device became available in the U.S. in January 2015.

“Epimed is the gold standard in its field, and we are proud to embrace the Epimed team as our partners.”

Tweet this

“This is an extremely significant partnership that will dramatically accelerate the introduction of Stimwave’s Wireless Pain Relief™ technology not only to physicians across the country, but more importantly to the millions of chronic pain patients who will benefit from it,” said Stimwave Chairman Laura Tyler Perryman. “Epimed is the gold standard in its field, and we are proud to embrace the Epimed team as our partners.”

“Since our founding 30 years ago, Epimed International has been dedicated to providing high-quality, effective products and tools to assist with acute and chronic pain management. Stimwave’s Wireless Pain Relief™ technology represents a giant step forward in this quest. We are excited and honored to announce this partnership and very much look forward to adding this novel technology to the family of pain management tools offered by Epimed to the field,” said Gabor J. Racz, CEO of Epimed International.

The partnership will include Stimwave utilization of Epimed’s manufacturing, packaging, fulfillment, distribution, reimbursement and physician services. Epimed has established a proven team for immediate response to meet the demand for Stimwave products, with facilities located in Upstate New York, the Dallas/Fort Worth area and representatives across the US. Epimed has been a valued contributor in procedural demonstrations through national and local workshops to assist physicians in treating chronic and acute pain.

Through this partnership, the Stimwave and Epimed team are further focused on a strong commitment to physician assistance for further advancement of interventional pain management techniques.

Please visit www.stimwave.com for more information on the availability of Stimwave.

About Stimwave

Stimwave Technologies Incorporated is a privately held medical device company engaged in the development, manufacture, and commercialization of wirelessly powered, injectable, microtechnology neurostimulators, providing patients with a convenient, safe, minimally invasive, and highly cost-effective pain-management solution that is easily incorporated into their daily lives. Stimwave’s goal is to evolve its patented, cutting-edge platform into the default for neuromodulation, increasing its accessibility for patients worldwide while lowering the economic impact of pain management.

About Epimed

Epimed focuses on developing solutions for experts in Pain Management, Regional Anesthesia, Radio Frequency, and Original Equipment Manufacturer (OEM) capabilities. Their main focus is to provide high-quality effective products and tools to assist with acute and chronic back pain. With their manufacturing plant located in Johnstown, New York, and facilities in the Dallas-Fort Worth area, they are a global resource for OEM Manufacturing, developing safe specialty products and devices for small-scale operations to several fortune 500 companies, with an increasing customer base in Europe, North America, South America, and Asia. www.epimedpain.com

Contacts

Glodow Nead Communications
Evan Nicholson or Sonia Meyer, 415-394-6500
stimwavepr@glodownead.com.